A detailed history of Valeo Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 80,490 shares of ABBV stock, worth $14.5 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
80,490
Previous 80,053 0.55%
Holding current value
$14.5 Million
Previous $13.7 Million 15.77%
% of portfolio
0.42%
Previous 0.39%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$163.84 - $199.33 $71,598 - $87,107
437 Added 0.55%
80,490 $15.9 Million
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $105,102 - $122,736
-679 Reduced 0.84%
80,053 $13.7 Million
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $148,312 - $168,988
928 Added 1.16%
80,732 $14.7 Million
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $173,404 - $197,578
1,085 Added 1.38%
79,804 $14.5 Million
Q4 2023

Jan 29, 2024

SELL
$137.6 - $154.97 $98,108 - $110,493
-713 Reduced 0.9%
78,719 $12.2 Million
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $372,582 - $431,318
2,789 Added 3.64%
79,432 $11.8 Million
Q2 2023

Jul 14, 2023

BUY
$132.51 - $164.9 $264,489 - $329,140
1,996 Added 2.67%
76,643 $10.3 Million
Q1 2023

Apr 17, 2023

BUY
$144.61 - $166.54 $372,949 - $429,506
2,579 Added 3.58%
74,647 $11.9 Million
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $121,297 - $145,467
-877 Reduced 1.2%
72,068 $11.7 Million
Q3 2022

Oct 31, 2022

BUY
$134.21 - $153.93 $462,085 - $529,980
3,443 Added 4.95%
72,945 $5.14 Million
Q2 2022

Aug 03, 2022

SELL
$137.62 - $174.96 $1.62 Million - $2.06 Million
-11,773 Reduced 14.49%
69,502 $5.34 Million
Q1 2022

Apr 28, 2022

SELL
$131.98 - $163.75 $19,665 - $24,398
-149 Reduced 0.18%
81,275 $7.55 Million
Q4 2021

Jan 07, 2022

BUY
$107.43 - $135.93 $1,718 - $2,174
16 Added 0.02%
81,424 $6.33 Million
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $636,591 - $722,626
5,983 Added 7.93%
81,408 $5.05 Million
Q2 2021

Jul 22, 2021

SELL
$105.21 - $117.21 $69,122 - $77,006
-657 Reduced 0.86%
75,425 $4.6 Million
Q1 2021

Apr 12, 2021

SELL
$102.3 - $112.62 $2.27 Million - $2.5 Million
-22,155 Reduced 22.55%
76,082 $4.49 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $5.31 Million - $7.16 Million
65,915 Added 203.93%
98,237 $4.08 Million
Q3 2020

Oct 28, 2020

BUY
$85.91 - $100.83 $16,838 - $19,762
196 Added 0.61%
32,322 $2.83 Million
Q2 2020

Jul 20, 2020

BUY
$73.37 - $98.18 $229,501 - $307,107
3,128 Added 10.79%
32,126 $3.15 Million
Q1 2020

Apr 13, 2020

BUY
$64.5 - $97.79 $148,672 - $225,405
2,305 Added 8.64%
28,998 $2.31 Million
Q4 2019

Jan 24, 2020

BUY
$72.13 - $90.25 $681,844 - $853,133
9,453 Added 54.83%
26,693 $2.36 Million
Q3 2019

Oct 15, 2019

BUY
$62.98 - $75.72 $155,623 - $187,104
2,471 Added 16.73%
17,240 $1.31 Million
Q2 2019

Jul 10, 2019

BUY
$65.7 - $83.98 $225,548 - $288,303
3,433 Added 30.28%
14,769 $1.07 Million
Q1 2019

Apr 12, 2019

BUY
$77.14 - $90.79 $4,628 - $5,447
60 Added 0.53%
11,336 $914,000
Q4 2018

Jan 30, 2019

SELL
$77.85 - $96.01 $28,726 - $35,427
-369 Reduced 3.17%
11,276 $1.04 Million
Q3 2018

Nov 01, 2018

SELL
$88.91 - $98.84 $50,056 - $55,646
-563 Reduced 4.61%
11,645 $912,000
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $53,149 - $62,888
592 Added 5.1%
12,208 $1.18 Million
Q1 2018

Apr 12, 2018

BUY
$92.01 - $123.21 $237,569 - $318,128
2,582 Added 28.58%
11,616 $1.1 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $187,449 - $205,553
-2,093 Reduced 18.81%
9,034 $874,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $777,220 - $992,750
11,127
11,127 $989,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.